FDA’s Good Review Management Practices To Debut In “Near Future”
This article was originally published in The Pink Sheet Daily
Executive Summary
Even as the agency wrestles with the transformation brought by FDAAA, shifts in how it processes NDAs may be the "most important," CDER official says.
You may also be interested in...
FDA Says New GRMPs Will Shift Drug Review Workload To Earlier In Cycle
Sponsors and FDA reviewers will have to adjust to the workload of a drug review shifting earlier in the review cycle as the agency implements Good Review Management Principles, now renamed the "21 Century Review Process.
FDA Says New GRMPs Will Shift Drug Review Workload To Earlier In Cycle
Sponsors and FDA reviewers will have to adjust to the workload of a drug review shifting earlier in the review cycle as the agency implements Good Review Management Principles, now renamed the "21 Century Review Process.
Good Review Principles Implementation Could Threaten Six-Month Priority Review Timeframe
OND Director Jenkins tells FDC/Windhover conference that newly-defined best practices are difficult to accomplish within six months and "nearly impossible" if the priority application must face an advisory panel.